Investigates enzymatic decarboxylation efficiency in deep eutectic solvents, indicating practical challenges for industrial use.
Deep eutectic solvents (DESs) can be designed to be enzyme-compatible and substrate solubilizers. Most biocatalytic reactions in DESs are conducted at small scale, and assessing how to scale up DES-based enzymatic reactions is necessary to assess their feasibility and associated challenges. This work studies the viability of using DESs with a phenolic acid decarboxylase (PAD) to synthesize 4-vinylguaiacol (4-VG) from ferulic acid. Upon PAD immobilization, the reaction is performed in a betaine–glycerol DES (1:2) with 20 vol % buffer in a rotating bed reactor (RBR) at the 120 mL scale. Full conversion of 300 mM ferulic acid (∼58 g/L) is achieved within 18 h at the 10 mL scale. However, challenges a substrate loadings are intended (1 M ferulic acid, ∼200 g/L) in the RBR at 120 mL, where ∼60% conversion is obtained, with a productivity of ∼10 g product/L/h. The formation of CO2 during the decarboxylation adds complexity at high substrate loadings, as part of the CO2 remains in the DESs and may change the physical–chemical properties. The produced 4-VG can be extracted with heptane (∼29% high-purity, one single extraction step). Overall, results demonstrate the feasibility of the DES/biocatalyst in RBRs for industrial applications, although they also reflect unexpected challenges (e.g., CO2 accumulation, low conversions). Research is needed to understand the pre-scale-up of DES-biocatalytic systems, as well as in the identification of biogenic alternatives for liquid–liquid separations.
No takes yet. Share an insight, caveat, or question.
Vaupel et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: